CHA submitted a statement for the record for the House Energy and Commerce Oversight and Investigations Subcommittee hearing, “Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply Chains.” Our statement calls on Congress to prioritize the unique health care needs of children when strengthening and stabilizing the nation’s supply chain to forestall shortages. Solutions include requiring manufacturer and distributor transparency, developing proactive shortage mitigation plans, and directing resources to the research and development of pediatric drugs.
CHA Submits Drug Shortages Hearing Statement for the Record
CHA submitted a statement for a House Energy and Commerce hearing to highlight how children’s needs must be prioritized when strengthening the pediatric drug supply chain.
Related Content
CHA Reacts to United States v. Skrmetti Decision
Drug Shortages Continue to Impact Children’s Hospitals
Improving Pediatric Emergency Care at Rural Hospitals
CHA Reacts to United States v. Skrmetti Decision
CHA remains steadfast in supporting the rights of patients and families to access high-quality gender-affirming care, guided by specialty-trained physicians.
June 18, 2025
Drug Shortages Continue to Impact Children’s Hospitals
Supply chain disruptions strain children’s hospital budgets, staffing, and patient care.
June 17, 2025
Improving Pediatric Emergency Care at Rural Hospitals
Primary Children’s Hospital is preparing rural hospitals across five states to care for critically ill kids.
June 17, 2025
